Active Surveillance—Is It Feasible for Intermediate-risk Localised Prostate Cancer?

Active Surveillance—Is It Feasible for Intermediate-risk Localised Prostate Cancer?

Background: Although active surveillance (AS) is a well-recognised treatment option for localised low-risk prostate cancer (LRPC), its role in the management of localised intermediate-risk prostate cancer (IRPC) is not clear yet and the available literature is slightly contradictory. Objective: To c...

Full description

Bibliographic Details
Main Authors: Subhabrata Mukherjee, Ioannis Promponas, Neophytos Petrides, Dafader Hossain, Jayasimha Abbaraju, Sanjeev Madaan
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:European Urology Open Science
Subjects:
Prostate cancer
Active surveillance
Low-risk prostate cancer
Intermediate-risk prostate cancer
Prostate-specific antigen
Magnetic resonance imaging
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168320363837

Internet

http://www.sciencedirect.com/science/article/pii/S2666168320363837

Similar Items